ONO-5334

DRUG2 trials

Sponsors

Ono Pharma USA Inc, Ono Pharmaceutical Co. Ltd

Conditions

Healthy Post Menopausal WomenOsteopeniaOsteoporosis

Phase 1

A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women

CompletedNCT01384188

Ono Pharmaceutical Co. LtdHealthy Post Menopausal Women

Start: 2011-06-30End: 2012-12-31Updated: 2013-01-18

Phase 2

Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis

CompletedNCT00532337

Ono Pharma USA IncOsteopenia, Osteoporosis

Start: 2007-10-31Updated: 2012-06-13

Related Papers

Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial.

2015-10-077 citations